Intelligence · Clinical Pipeline
GSK Glaxo Smith Pipeline
All ClinicalTrials.gov programs at GSK Glaxo Smith — phase, modality, and trial IDs.
- Programs
- 70
Quick answer
GSK Glaxo Smith has 70 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, Prevenar 13 suspension for injection pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Rotarix oral suspension in pre-filled oral applicator Rotavirus vaccine, live, Infanrix hexa, Powder and suspension for suspension for injection. Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IP
GlaxoSmithKline
Infections, Meningococcal
1 trial -
Other: Placebo
GlaxoSmithKline
Menopausal and Female Climacteric States
1 trial -
POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, CARFILZOMIB, BORTEZOMIB, POMALIDOMIDE, CARFILZOMIB, POMALIDOMIDE, CARFILZOMIB, DEXAMETHASONE
GlaxoSmithKline
Relapsed or Refractory Multiple Myeloma
1 trial -
Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion., KEYTRUDA 25 mg/mL concentrate for solution for infusion, Carboplatin-Teva 10 mg/ml Concentrate for Solution for Infusion, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion, JEMPERLI 500 mg concentrate for solution for infusion, Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion., Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion.
GlaxoSmithKline
Lung Cancer, Non-Small Cell
1 trial -
Placebo for Bepirovirsen Solution for Injection, 150 mg/mL SSD
GlaxoSmithKline
Hepatitis B
1 trial -
Placebo for GSK5784283.
GlaxoSmithKline
Asthma
1 trial -
Placebo to Match GSK3915393 Tablet
GlaxoSmithKline
Idiopathic Pulmonary Fibrosis
1 trial -
Placebo to Match GSK3965193 Tablets
GlaxoSmithKline
Hepatitis B
1 trial -
Reblozyl 75 mg powder for solution for injection
GlaxoSmithKline
Myelofibrosis
1 trial -
Rotarix™
GlaxoSmithKline
Infections, Rotavirus
1 trial -
SB497115
GlaxoSmithKline
Purpura, Thrombocytopaenic, Idiopathic
1 trial -
SB497115
GlaxoSmithKline
Thrombocytopaenia
1 trial -
SERETIDE Rotacaps
GlaxoSmithKline
Asthma
1 trial -
Sodium Chloride Intravenous Infusion (0.9% w/v), BP, Benlysta 400 mg powder for concentrate for solution for infusion.
GlaxoSmithKline
Systemic Lupus Erythematosus
1 trial -
Solabegron
GlaxoSmithKline
Overactive Bladder
1 trial -
Zejula 100 mg film-coated tablets, Zejula 100 mg film-coated tablets
GlaxoSmithKline
Neoplasms
1 trial -
albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
dabrafenib
GlaxoSmithKline
Solid Tumours
1 trial -
meningococcal ACWY (vaccine)
GlaxoSmithKline
Infections, Meningococcal
1 trial -
pazopanib (GW786034)
GlaxoSmithKline
Neoplasms, Uterine Cervix
1 trial -
pazopanib (GW786034) 400 mg
GlaxoSmithKline
Neoplasms, Breast
1 trial -
sterile saline solution (0.9% w/v solution of NaCl in water).
GlaxoSmithKline
Urinary Tract Infections
1 trial
Frequently asked questions
How many pipeline programs does GSK Glaxo Smith have?
70 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs